ClinicalTrials.gov
ClinicalTrials.gov Menu

Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00039494
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : August 2, 2013
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)